Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FE 999901 (Dinoprostone) for Cervical Ripening
NCT03067597Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Feb 2017
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dinoprostone in cervical ripening (CR), sponsored by Ferring Pharmaceuticals. Started Feb 2017; status: completed.
02
Drugs
dinoprostone
03
Conditions
cervical ripening (CR)
Beyond the preview
Go deeper on NCT03067597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03067597.